<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156246">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01065701</url>
  </required_header>
  <id_info>
    <org_study_id>InDex3</org_study_id>
    <nct_id>NCT01065701</nct_id>
  </id_info>
  <brief_title>Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children</brief_title>
  <official_title>Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children - a Double-blinded Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intranasal dexmedetomidine has shown to be an effective sedative when used prior to
      anaesthetic induction as premedication. 1mcg/kg intranasal dexmedetomidine was used in
      previous study and it produced satisfactory sedation in more than 50% of the children at the
      time of anaesthetic induction with no adverse effect. In this study we aim to compare
      1mcg/kg with 2mcg/kg intranasal dexmedetomidine in children. We expect more children would
      attain satisfactory sedation prior to anaesthetic induction when higher dose is used.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">June 2010</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of children attained satisfactory sedation</measure>
    <time_frame>one hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to onset of sedation</measure>
    <time_frame>one hour</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Patient Between 1-8 Years Old Undergoing Elective Surgery at Queen Mary Hospital</condition>
  <arm_group>
    <arm_group_label>1mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1mcg/kg intranasal dexmedetomidine administered 45 minutes befoe anesthesia induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2mcg/kg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2mcg/kg intranasal dexmedetomidine given 45 minutes prior to anesthetic induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Intranasal dexmedetomidine is given as premedication prior to induction of anesthesia</description>
    <arm_group_label>1mcg/kg</arm_group_label>
    <arm_group_label>2mcg/kg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 1-12 years old

          -  American Society of Anesthesiologists (ASA) 1-2

          -  Elective surgery

          -  Children with autism or pervasive personality disorder

        Exclusion Criteria:

          -  American Society of Anaesthesiologists (ASA) 3-5

          -  Allergy or hypersensitive reaction to dexmedetomidine

          -  Known cardiac arrhythmia or congenital heart disease

          -  Mentally disabled
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivian M Yuen, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Consultant, Queen Mary Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vivian M Yuen, MBBS</last_name>
    <phone>853 93034274</phone>
    <email>vtang131@hku.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>QUeen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vivian M Yuen, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <lastchanged_date>February 8, 2010</lastchanged_date>
  <firstreceived_date>February 7, 2010</firstreceived_date>
  <responsible_party>
    <name_title>Dr. Vivian Man-ying YUEN</name_title>
    <organization>Queen Mary Hospital</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
